First National Bank Of Hutchinson Biogen Inc. Transaction History

First National Bank Of Hutchinson

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 22, 2019	SELL	$216.71 - $338.96 $442,088 - $691,478	-2,040 Closed	0 $0
Q4 2018 Jan 30, 2019	SELL	$278.5 - $352.75 $6,684 - $8,466	-24 Reduced 1.16%	2,040 $614,000
Q3 2018 Oct 26, 2018	BUY	$293.51 - $383.83 $68,387 - $89,432	233 Added 12.73%	2,064 $729,000
Q2 2018 Jul 12, 2018	SELL	$257.52 - $306.91 $38,112 - $45,422	-148 Reduced 7.48%	1,831 $531,000
Q1 2018 Apr 30, 2018	SELL	$260.13 - $367.91 $42,401 - $59,969	-163 Reduced 7.61%	1,979 $542,000
Q4 2017 Jan 29, 2018	SELL	$307.64 - $344.58 $5,845 - $6,547	-19 Reduced 0.88%	2,142 $682,000
Q3 2017 Oct 17, 2017	BUY	$281.15 - $329.69 $607,565 - $712,460	2,161	2,161 $686,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of First National Bank Of Hutchinson, based on Form 13F filings with the SEC.

Stay updated on First National Bank Of Hutchinson with notifications on news.